This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
immune response | 555 |
results suggest | 540 |
mouse model | 528 |
immune responses | 492 |
gene expression | 490 |
virus infection | 467 |
mg kg | 444 |
present study | 443 |
cell lines | 436 |
class i | 392 |
infected mice | 391 |
nervous system | 389 |
immune system | 381 |
transgenic mice | 373 |
bone marrow | 370 |
cell death | 359 |
clinical signs | 342 |
mouse models | 337 |
epithelial cells | 334 |
animal models | 331 |
cell line | 329 |
spinal cord | 304 |
deficient mice | 277 |
stem cells | 272 |
lymph nodes | 272 |
cell types | 272 |
dendritic cells | 271 |
research funds | 269 |
important role | 269 |
results indicate | 266 |
cell surface | 262 |
hepatitis virus | 261 |
central nervous | 258 |
inflammatory response | 255 |
amino acid | 251 |
humanized mice | 249 |
peripheral blood | 248 |
tg mice | 246 |
flow cytometry | 245 |
influenza virus | 239 |
endothelial cells | 235 |
mouse hepatitis | 233 |
data suggest | 232 |
cell proliferation | 232 |
wild type | 230 |
guinea pigs | 229 |
weight loss | 229 |
ng ml | 228 |
ko mice | 224 |
pg ml | 221 |
monoclonal antibodies | 220 |
animal model | 220 |
cd cd | 218 |
body weight | 217 |
laboratory mice | 216 |
adult mice | 211 |
type i | 209 |
growth factor | 207 |
mrna expression | 204 |
skeletal muscle | 204 |
laboratory animals | 204 |
significantly reduced | 204 |
bl mice | 204 |
may also | 199 |
cell responses | 196 |
respiratory tract | 195 |
cell activation | 190 |
mice infected | 187 |
oxidative stress | 186 |
significantly increased | 185 |
graduate school | 185 |
knockout mice | 184 |
acute respiratory | 183 |
monoclonal antibody | 182 |
transcription factor | 181 |
small intestine | 178 |
respiratory syndrome | 178 |
salivary glands | 177 |
taken together | 177 |
mhc class | 175 |
immune cells | 174 |
high levels | 169 |
smooth muscle | 168 |
mice showed | 168 |
protein expression | 165 |
mouse strains | 164 |
nitric oxide | 164 |
western blot | 163 |
dependent manner | 160 |
inflammatory cytokines | 158 |
innate immune | 158 |
molecular mechanisms | 157 |
cell culture | 156 |
stem cell | 156 |
necrosis factor | 155 |
tumor cells | 154 |
amino acids | 152 |
glial cells | 150 |
control group | 149 |
results show | 148 |
lung injury | 148 |
significantly higher | 147 |
microglial cells | 146 |
female mice | 145 |
cell receptor | 143 |
male mice | 143 |
previous studies | 139 |
control mice | 139 |
immunodeficient mice | 138 |
additional file | 138 |
laboratory animal | 137 |
septic shock | 137 |
days post | 136 |
severe acute | 135 |
type mice | 135 |
positive cells | 135 |
electron microscopy | 134 |
protein kinase | 134 |
progenitor cells | 134 |
tumor necrosis | 133 |
clinical trials | 133 |
mast cells | 132 |
cytokine production | 130 |
acute phase | 129 |
vaccinia virus | 128 |
transgenic mouse | 128 |
recent studies | 127 |
findings suggest | 127 |
time points | 127 |
cd cells | 126 |
dna damage | 126 |
significant increase | 126 |
senescent cells | 125 |
binding protein | 125 |
mg ml | 124 |
humanized mouse | 123 |
spleen cells | 123 |
mononuclear cells | 121 |
plasma membrane | 121 |
signal transduction | 120 |
cov infection | 120 |
data indicate | 119 |
nude mice | 119 |
previously described | 118 |
clinical disease | 118 |
may contribute | 117 |
ex vivo | 117 |
may occur | 115 |
cell cycle | 115 |
expression levels | 115 |
inbred strains | 114 |
treated mice | 114 |
scid mice | 113 |
viral infection | 113 |
fatty acid | 113 |
fatty acids | 112 |
inflammatory cell | 112 |
lymphocytic choriomeningitis | 112 |
may play | 112 |
blood vessels | 111 |
significant differences | 111 |
united states | 110 |
inflammatory cells | 110 |
virus replication | 109 |
also observed | 109 |
adhesion molecules | 108 |
muscle cells | 108 |
adipose tissue | 108 |
experimental infection | 108 |
transcription factors | 107 |
mice may | 107 |
mouse colonies | 107 |
human disease | 107 |
cell type | 106 |
neuronal activity | 106 |
also found | 106 |
lung tissue | 106 |
suckling mice | 106 |
cells expressing | 105 |
lamina propria | 104 |
performed using | 104 |
doc id | 104 |
blood pressure | 104 |
cord uid | 104 |
salivary gland | 103 |
wt mice | 103 |
mouse brain | 103 |
serum levels | 103 |
viral replication | 102 |
blot analysis | 102 |
cell response | 101 |
type ii | 101 |
infant mice | 100 |
immunocompetent mice | 100 |
proinflammatory cytokines | 99 |
results demonstrate | 99 |
nk cells | 99 |
national institute | 99 |
human immune | 99 |
sendai virus | 99 |
heart failure | 98 |
cell populations | 98 |
receptor antagonist | 98 |
infected animals | 98 |
mice lacking | 98 |
class ii | 98 |
analysis revealed | 97 |
specific cd | 97 |
squamous cell | 97 |
cell cultures | 97 |
blood flow | 96 |
reactive oxygen | 96 |
side effects | 95 |
previously reported | 94 |
determine whether | 94 |
infected cells | 94 |
inflammatory diseases | 94 |
multiple sclerosis | 94 |
infectious diseases | 94 |
reproductive tract | 93 |
old mice | 93 |
mechanisms underlying | 93 |
viral infections | 92 |
plasma levels | 92 |
inflammatory responses | 92 |
respiratory syncytial | 92 |
signaling pathways | 92 |
cerebral cortex | 92 |
blood samples | 91 |
significantly decreased | 91 |
situ hybridization | 91 |
two different | 91 |
converting enzyme | 90 |
mrna levels | 90 |
wistar rats | 90 |
adaptive immune | 90 |
rhesus macaques | 90 |
organ failure | 90 |
choriomeningitis virus | 89 |
syndrome coronavirus | 89 |
cell population | 89 |
extracellular matrix | 88 |
neutralizing antibodies | 88 |
presenting cells | 88 |
acinar cells | 87 |
chronic inflammation | 87 |
antibody responses | 87 |
syncytial virus | 86 |
mice immunized | 86 |
higher levels | 86 |
ca i | 86 |
gastrointestinal tract | 86 |
single cell | 86 |
innate immunity | 85 |
polymerase chain | 85 |
chain reaction | 85 |
antigen presentation | 85 |
stage hli | 85 |
dengue virus | 85 |
young mice | 85 |
lymph node | 85 |
mice treated | 84 |
pulmonary fibrosis | 84 |
nkt cells | 83 |
cell adhesion | 83 |
oxygen species | 83 |
significant difference | 83 |
antibody response | 83 |
research institute | 82 |
specific antibodies | 82 |
antigen presenting | 82 |
crucial role | 82 |
mass spectrometry | 82 |
influenza infection | 81 |
white matter | 81 |
also known | 81 |
commonly used | 81 |
natural killer | 81 |
basement membrane | 81 |
immune cell | 81 |
respiratory distress | 81 |
hematopoietic stem | 81 |
neural stem | 81 |
membrane potential | 81 |
disease progression | 81 |
mutant mice | 80 |
infectious disease | 80 |
i molecules | 80 |
western blotting | 79 |
cell clones | 79 |
th cells | 79 |
time point | 79 |
time pcr | 79 |
mouse strain | 79 |
schwann cells | 79 |
time course | 79 |
synaptic plasticity | 79 |
studies using | 78 |
previously shown | 78 |
human cd | 77 |
persistent infection | 77 |
binding site | 77 |
porcine apn | 77 |
mice compared | 77 |
oral cavity | 77 |
viral rna | 77 |
two groups | 77 |
critical role | 77 |
cell differentiation | 77 |
hippocampal neurons | 77 |
target cells | 77 |
lymphoid tissue | 77 |
tissue damage | 77 |
biomedical research | 77 |
aged mice | 76 |
inflammatory mediators | 76 |
naturally occurring | 76 |
increased expression | 76 |
protein synthesis | 76 |
surface expression | 76 |
synaptic transmission | 75 |
closely related | 75 |
guinea pig | 75 |
results showed | 75 |
normal mice | 75 |
endothelial cell | 75 |
cancer cells | 75 |
poorly understood | 75 |
angiotensin ii | 75 |
mast cell | 74 |
significantly lower | 74 |
tumor growth | 74 |
protective immunity | 74 |
laboratory mouse | 74 |
adverse effects | 74 |
severe disease | 73 |
first time | 73 |
cells may | 73 |
high affinity | 73 |
chronic inflammatory | 73 |
prefrontal cortex | 73 |
plasma cells | 72 |
mice expressing | 72 |
cell migration | 72 |
cell development | 72 |
endoplasmic reticulum | 72 |
west nile | 72 |
nlrp inflammasome | 72 |
middle east | 72 |
acinar cell | 71 |
molecular weight | 71 |
research council | 71 |
direct contact | 71 |
signaling pathway | 71 |
statistically significant | 71 |
commercially available | 71 |
purkinje cells | 71 |
phase i | 70 |
growth factors | 70 |
protective effect | 70 |
squamous epithelium | 70 |
binding sites | 70 |
animal care | 69 |
differential diagnosis | 69 |
high dose | 69 |
data show | 69 |
protein levels | 69 |
gene therapy | 69 |
hek cells | 69 |
cells showed | 69 |
room temperature | 69 |
whole blood | 68 |
rheumatoid arthritis | 68 |
brain injury | 68 |
fold increase | 68 |
data demonstrate | 68 |
multiple organ | 67 |
brain regions | 67 |
clinical symptoms | 67 |
septic patients | 67 |
type diabetes | 66 |
rat brain | 66 |
host defense | 66 |
may cause | 66 |
olfactory bulb | 66 |
key role | 66 |
national research | 66 |
epithelial cell | 66 |
pr virus | 66 |
hemorrhagic fever | 66 |
receptor activation | 66 |
herpes simplex | 66 |
inhibitory effect | 65 |
coupled receptors | 65 |
virus infections | 65 |
breast cancer | 65 |
specific ctl | 65 |
blood cells | 65 |
insulin resistance | 65 |
east respiratory | 64 |
hiv infection | 64 |
cell viability | 64 |
acute lung | 64 |
may lead | 64 |
per group | 64 |
increased levels | 64 |
myeloid cells | 63 |
may develop | 63 |
visual cortex | 63 |
brain science | 63 |
mhv infection | 63 |
experimentally infected | 63 |
neuropathic pain | 62 |
mice exhibited | 62 |
biological materials | 62 |
high doses | 62 |
neointimal formation | 62 |
low dose | 62 |
specific genes | 62 |
cell hyperplasia | 62 |
inflammatory bowel | 62 |
central role | 62 |
laboratory rodents | 62 |
murine model | 61 |
virus strain | 61 |
cell infiltration | 61 |
differentially expressed | 61 |
ms ms | 61 |
expression level | 61 |
widely used | 61 |
nmda receptor | 61 |
cell subsets | 61 |
dendritic cell | 61 |
neurodegenerative diseases | 61 |
autoimmune diseases | 61 |
university school | 60 |
toxicity studies | 60 |
within days | 60 |
zika virus | 60 |
like receptor | 60 |
cell membrane | 60 |
cortical neurons | 60 |
immunized mice | 60 |
distress syndrome | 60 |
cynomolgus macaques | 59 |
highly expressed | 59 |
tumor cell | 59 |
brain barrier | 59 |
candidate genes | 59 |
neonatal mice | 59 |
nipah virus | 59 |
male rats | 59 |
cell function | 59 |
findings indicate | 59 |
rat model | 59 |
see table | 59 |
mhv strains | 59 |
recent study | 58 |
intestinal mucosa | 58 |
inflammatory cytokine | 58 |
two distinct | 58 |
hla class | 58 |
drinking water | 58 |
wide range | 58 |
encephalitis virus | 57 |
inhibitory effects | 57 |
infectious virus | 57 |
major role | 57 |
significant decrease | 57 |
specific antibody | 57 |
beneficial effects | 57 |
significant reduction | 57 |
lactate dehydrogenase | 57 |
cellular immune | 57 |
culture medium | 57 |
simplex virus | 56 |
protein level | 56 |
mechanisms involved | 56 |
antibody production | 56 |
host immune | 56 |
morphological changes | 56 |
mice developed | 56 |
blt mice | 56 |
inkt cells | 56 |
rats treated | 56 |
human cells | 56 |
adhesion molecule | 56 |
animal species | 55 |
even though | 55 |
analysis showed | 55 |
ang ii | 55 |
tissue culture | 55 |
food intake | 55 |
bowel disease | 55 |
mus musculus | 55 |
neutralizing antibody | 55 |
small animal | 55 |
investigate whether | 55 |
respiratory disease | 55 |
mesenteric lymph | 54 |
mice using | 54 |
mice develop | 54 |
tissue injury | 54 |
well known | 54 |
therapeutic agents | 54 |
measured using | 54 |
lymphoid tissues | 54 |
mitochondrial dysfunction | 54 |
severe cases | 54 |
infectious agents | 54 |
effector cells | 54 |
may provide | 54 |
real time | 54 |
brain tissue | 54 |
null mice | 54 |
cd expression | 54 |
expression pattern | 54 |
microglial activation | 54 |
fold higher | 53 |
fat diet | 53 |
osaka univ | 53 |
university graduate | 53 |
inbred mice | 53 |
research complications | 53 |
ng cells | 53 |
electron microscopic | 53 |
control animals | 53 |
connective tissue | 53 |
large number | 53 |
bovine serum | 53 |
reporter gene | 53 |
upper respiratory | 53 |
vitro studies | 53 |
investigated whether | 53 |
two weeks | 53 |
lymphoid organs | 53 |
healthy controls | 53 |
oxide synthase | 53 |
gastric mucosa | 53 |
wound healing | 53 |
immunodeficiency virus | 52 |
virus strains | 52 |
long term | 52 |
model system | 52 |
intranasal inoculation | 52 |
clinical trial | 52 |
alveolar macrophages | 52 |
clinical studies | 52 |
lung inflammation | 52 |
may result | 52 |
apoptotic cells | 52 |
nose pokes | 51 |
coupled receptor | 51 |
inflammatory process | 51 |
receptor expression | 51 |
fusion protein | 51 |
least one | 51 |
cellular senescence | 51 |
different cell | 51 |
three different | 51 |
mice inoculated | 51 |
bacterial infections | 51 |
heart rate | 51 |
goblet cells | 51 |
healthy volunteers | 51 |
insulin secretion | 51 |
kyoto university | 51 |
dose dependent | 51 |
host response | 51 |
bronchoalveolar lavage | 51 |
energy metabolism | 51 |
equine encephalitis | 51 |
gross lesions | 51 |
important roles | 51 |
arachidonic acid | 51 |
vg vd | 50 |
mouse line | 50 |
mechanical ventilation | 50 |
stimulating factor | 50 |
like receptors | 50 |
control groups | 50 |
previously published | 50 |
different time | 50 |
nsg mice | 50 |
heavy chain | 50 |
newborn mice | 50 |
medical school | 50 |
tyrosine kinase | 50 |
cell growth | 50 |
mortality rate | 50 |
inflammatory reaction | 50 |
nile virus | 50 |
type iii | 50 |
confocal microscopy | 50 |
neuronal cell | 49 |
immunosorbent assay | 49 |
molecular mechanism | 49 |
inflammatory processes | 49 |
embryo transfer | 49 |
dorsal root | 49 |
low levels | 49 |
cx cr | 49 |
human lung | 49 |
blood glucose | 49 |
viral antigens | 49 |
pivotal role | 49 |
wild mice | 49 |
two types | 49 |
previously identified | 49 |
intraperitoneal injection | 49 |
facs analysis | 49 |
humoral immune | 49 |
vascular smooth | 49 |
blood mononuclear | 49 |
pharmakologie und | 49 |
animal medicine | 49 |
ca region | 49 |
recent years | 49 |
protective role | 49 |
male reproductive | 49 |
hippocampal slices | 49 |
pyramidal neurons | 49 |
mice also | 48 |
post infection | 48 |
days later | 48 |
better understanding | 48 |
mice subjected | 48 |
glucose levels | 48 |
dentate gyrus | 48 |
motor neurons | 48 |
high concentrations | 48 |
mammary gland | 48 |
new therapeutic | 48 |
peritoneal macrophages | 48 |
significantly different | 48 |
showed significant | 48 |
adrenergic receptor | 48 |
antigen processing | 48 |
primary human | 48 |
treated animals | 48 |
neurite outgrowth | 48 |
sensory neurons | 48 |
adaptive immunity | 48 |
body temperature | 48 |
treated rats | 47 |
different types | 47 |
acid sequence | 47 |
virus type | 47 |
producing cells | 47 |
collaborative cross | 47 |
und toxikologie | 47 |
inflammasome activation | 47 |
cell carcinoma | 47 |
nose poke | 47 |
linked immunosorbent | 47 |
submandibular gland | 47 |
expression patterns | 47 |
viral antigen | 47 |
molecular biology | 47 |
fluorescent protein | 46 |
expressing cells | 46 |
pyramidal cells | 46 |
also used | 46 |
es cells | 46 |
highly conserved | 46 |
per mouse | 46 |
cytokine levels | 46 |
neuronal death | 46 |
granule cells | 46 |
genomic dna | 46 |
genetically modified | 46 |
binding proteins | 46 |
mice exposed | 46 |
enzyme activity | 46 |
molecular basis | 46 |
cells within | 46 |
studies showed | 46 |
genes involved | 46 |
precursor cells | 45 |
mononuclear cell | 45 |
previous study | 45 |
nk cell | 45 |
red blood | 45 |
small intestinal | 45 |
dawley rats | 45 |
risk assessment | 45 |
therapeutic potential | 45 |
airway inflammation | 45 |
risk factors | 45 |
mg dl | 45 |
cardiac hypertrophy | 45 |
chronic infection | 45 |
host cells | 45 |
human primates | 45 |
foxn nu | 45 |
mouse ifn | 45 |
wide variety | 45 |
activated protein | 45 |
prkdc scid | 45 |
specific igg | 45 |
cord blood | 45 |
adoptive transfer | 45 |
olfactory epithelium | 44 |
gene transfer | 44 |
culture system | 44 |
ms patients | 44 |
human peripheral | 44 |
reactive astrocytes | 44 |
murine models | 44 |
lower respiratory | 44 |
nerve injury | 44 |
total rna | 44 |
natural infection | 44 |
increased risk | 44 |
large intestine | 44 |
specific immune | 44 |
similar results | 44 |
evidence suggests | 44 |
induced apoptosis | 44 |
coronavirus infection | 44 |
mediated immune | 43 |
gnrh neurons | 43 |
like cells | 43 |
experimental animals | 43 |
interstitial pneumonia | 43 |
influenza viruses | 43 |
binding domain | 43 |
adult rats | 43 |
kg day | 43 |
also showed | 43 |
high mortality | 43 |
actin cytoskeleton | 43 |
recombinant human | 43 |
inbred mouse | 43 |
viral load | 43 |
host range | 43 |
genetic background | 43 |
tissue sections | 43 |
epidermal growth | 43 |
autoimmune disease | 43 |
incubation period | 43 |
future studies | 43 |
medical university | 43 |
activated microglia | 43 |
frequently used | 43 |
signalling pathways | 43 |
immune function | 43 |
microarray analysis | 43 |
gel electrophoresis | 43 |
intestinal tract | 43 |
functional role | 43 |
genetically engineered | 42 |
intestinal metaplasia | 42 |
dna repair | 42 |
cb infected | 42 |
preliminary results | 42 |
sequence analysis | 42 |
serum samples | 42 |
determined using | 42 |
vascular endothelial | 42 |
may explain | 42 |
hace mice | 42 |
viral loads | 42 |
hemorrhagic shock | 42 |
total number | 42 |
experimental model | 42 |
specific igy | 42 |
human immunodeficiency | 42 |
studies suggest | 42 |
nmda receptors | 42 |
remains unclear | 42 |
human brain | 41 |
femoral artery | 41 |
potential therapeutic | 41 |
cancer cell | 41 |
cell epitopes | 41 |
systemic inflammatory | 41 |
monkeypox virus | 41 |
target genes | 41 |
science institute | 41 |
myocardial infarction | 41 |
histopathological changes | 41 |
weeks old | 41 |
glial cell | 41 |
promoter activity | 41 |
susceptible mice | 41 |
per cent | 41 |
animal studies | 41 |
substantia nigra | 41 |
cells express | 41 |
osaka university | 41 |
genetic diversity | 41 |
ion channels | 41 |
hydrogen peroxide | 41 |
described previously | 41 |
intracellular ca | 41 |
transforming growth | 41 |
cell survival | 41 |
reproductive tissue | 41 |
mouse lines | 41 |
provide evidence | 41 |
gene products | 40 |
action potentials | 40 |
intracellular calcium | 40 |
glucose tolerance | 40 |
analysis using | 40 |
cell biology | 40 |
cells also | 40 |
public health | 40 |
research center | 40 |
day post | 40 |
acute pancreatitis | 40 |
myeloid cell | 40 |
strand breaks | 40 |
results obtained | 40 |
lymphoid cells | 40 |
sars coronavirus | 40 |
hepatocellular carcinoma | 40 |
will discuss | 40 |
first step | 40 |
murine hepatitis | 40 |
pulmonary edema | 40 |
neuronal cells | 40 |
examined whether | 40 |
dopaminergic neurons | 40 |
minute virus | 40 |
human skin | 39 |
ebola virus | 39 |
stress response | 39 |
nasal cavity | 39 |
mediated immunity | 39 |
protective effects | 39 |
cancer patients | 39 |
natural infections | 39 |
muscularis mucosa | 39 |
growth pattern | 39 |
embryonic stem | 39 |
better understand | 39 |
immunohistochemical analysis | 39 |
mouse genome | 39 |
basal cell | 39 |
largely unknown | 39 |
may represent | 39 |
vivo imaging | 39 |
highly susceptible | 39 |
cell activity | 39 |
statistical analysis | 39 |
antibody titers | 39 |
specific expression | 39 |
gene transcription | 39 |
antitumor activity | 38 |
vivo studies | 38 |
fusion proteins | 38 |
platelet aggregation | 38 |
inflammatory conditions | 38 |
acute infection | 38 |
cytokine release | 38 |
rats exposed | 38 |
healthy subjects | 38 |
mammalian cells | 38 |
living cells | 38 |
pathological conditions | 38 |
modified vaccinia | 38 |
within hours | 38 |
morphologic features | 38 |
i ifn | 38 |
critically ill | 38 |
rat hippocampal | 38 |
synthetic peptides | 38 |
mice per | 38 |
persistently infected | 38 |
several studies | 38 |
elevating virus | 38 |
squamous metaplasia | 38 |
signalling pathway | 38 |
days postinfection | 38 |
results indicated | 38 |
brain development | 38 |
novel therapeutic | 38 |
also occur | 38 |
intensive care | 38 |
disease severity | 38 |
diabetes mellitus | 38 |
ctl response | 38 |
murine cytomegalovirus | 37 |
high fat | 37 |
brain parenchyma | 37 |
significantly enhanced | 37 |
may help | 37 |
cell layer | 37 |
viral titers | 37 |
stranded rna | 37 |
inbred strain | 37 |
oral administration | 37 |
elevated levels | 37 |
group i | 37 |
developmental stages | 37 |
tissue distribution | 37 |
cell numbers | 37 |
organ dysfunction | 37 |
analyzed using | 37 |
alkaline phosphatase | 37 |
i interferon | 37 |
expression profiles | 37 |
early phase | 37 |
human ifn | 37 |
cell sorting | 37 |
immunized via | 37 |
disease caused | 37 |
statistical significance | 37 |
experimental models | 37 |
encephalomyelitis virus | 37 |
ctl responses | 37 |
studies indicate | 37 |
reverse transcriptase | 37 |
tissue samples | 37 |
data obtained | 37 |
whole body | 37 |
ca influx | 37 |
will provide | 36 |
induced cell | 36 |
acute inflammatory | 36 |
vitro model | 36 |
may influence | 36 |
map kinase | 36 |
diagnostic criteria | 36 |
animal experiments | 36 |
therapeutic target | 36 |
kg bw | 36 |
hybridoma technology | 36 |
preclinical studies | 36 |
host cell | 36 |
skin lesions | 36 |
scid il | 36 |
tca cycle | 36 |
mice show | 36 |
left ventricular | 36 |
fever virus | 36 |
nu mice | 36 |
toxoplasma gondii | 36 |
staphylococcus aureus | 36 |
antiviral activity | 36 |
escherichia coli | 36 |
lethal infection | 36 |
family members | 36 |
growth cone | 36 |
mice fed | 36 |
plasma concentrations | 36 |
experimental conditions | 36 |
cardiovascular disease | 36 |
preliminary data | 36 |
tnf production | 36 |
underlying mechanisms | 36 |
mice housed | 36 |
essential role | 36 |
microglial cell | 36 |
virus particles | 36 |
proliferative response | 36 |
vitro experiments | 36 |
infected patients | 36 |
life span | 36 |
human health | 36 |
clinical chemistry | 36 |
pseudomonas aeruginosa | 36 |
senescent cell | 36 |
rabies virus | 35 |
new york | 35 |
play important | 35 |
human hematopoietic | 35 |
mouse serum | 35 |
bacterial infection | 35 |
toxic effects | 35 |
ectromelia virus | 35 |
human monocytes | 35 |
days old | 35 |
major histocompatibility | 35 |
new insights | 35 |
brain function | 35 |
erosion ulcer | 35 |
colorectal cancer | 35 |
mice received | 35 |
expression analysis | 35 |
therapeutic strategies | 35 |
also may | 35 |
pulmonary inflammation | 35 |
three weeks | 35 |
results suggested | 35 |
cells derived | 35 |
early stages | 35 |
cell number | 35 |
weight gain | 35 |
experimental studies | 35 |
hair coat | 35 |
clostridium difficile | 35 |
studies will | 35 |
lipid metabolism | 35 |
lower levels | 35 |
membrane integrity | 35 |
possible role | 35 |
serum albumin | 35 |
programmed cell | 34 |
cd positive | 34 |
mesenchymal stem | 34 |
demyelinating disease | 34 |
differential expression | 34 |
i i | 34 |
colon cancer | 34 |
mitochondrial membrane | 34 |
way anova | 34 |
university hospital | 34 |
target cell | 34 |
north america | 34 |
paneth cells | 34 |
physiological conditions | 34 |
culture supernatants | 34 |
also increased | 34 |
pneumonia virus | 34 |
dtg mice | 34 |
carotid artery | 34 |
cuff placement | 34 |
postnatal day | 34 |
syrian hamsters | 34 |
incorrect nose | 34 |
protein coupled | 34 |
inflammatory disease | 34 |
cotton rats | 34 |
pcr analysis | 34 |
neurotrophic factor | 34 |
liver injury | 34 |
blood lymphocytes | 34 |
cytokine response | 34 |
term potentiation | 34 |
basal lamina | 34 |
gram negative | 34 |
survival rate | 34 |
using two | 34 |
female rats | 34 |
histological examination | 34 |
naturally infected | 34 |
adverse events | 34 |
adult male | 34 |
ruffled fur | 34 |
renal failure | 34 |
enterotropic mhv | 33 |
survival time | 33 |
experimental autoimmune | 33 |
induced lung | 33 |
pdm infection | 33 |
may affect | 33 |
histocompatibility complex | 33 |
antibiotic treatment | 33 |
hippocampal ca | 33 |
environmental factors | 33 |
combined term | 33 |
serum il | 33 |
northern blot | 33 |
low concentrations | 33 |
significant changes | 33 |
athymic nude | 33 |
tohoku university | 33 |
treatment groups | 33 |
healthy donors | 33 |
membrane proteins | 33 |
engineered mice | 33 |
helper cells | 33 |
medical center | 33 |
expression profile | 33 |
gabaergic neurons | 33 |
significantly elevated | 33 |
intestinal inflammation | 33 |
mice following | 33 |
acid secretion | 33 |
rhesus monkeys | 33 |
knockout mouse | 33 |
protective immune | 33 |
kyoto univ | 33 |
mrna level | 33 |
reactive protein | 33 |
nadph oxidase | 33 |
standard deviation | 33 |
male wistar | 33 |
negative bacteria | 33 |
chronic disease | 33 |
dependent protein | 33 |
gastric cancer | 33 |
human infection | 33 |
mice deficient | 33 |
murine coronavirus | 33 |
risk factor | 33 |
significant role | 33 |
optic nerve | 33 |
adult mouse | 33 |
cell infiltrate | 32 |
thyroid hormone | 32 |
small size | 32 |
projection neurons | 32 |
mouse parvovirus | 32 |
intestinal epithelium | 32 |
leukemia virus | 32 |
hela cells | 32 |
liver enzymes | 32 |
might contribute | 32 |
assessed using | 32 |
significantly inhibited | 32 |
phase ii | 32 |
microglia activation | 32 |
life cycle | 32 |
wildtype mice | 32 |
causative agent | 32 |
recently shown | 32 |
vascular permeability | 32 |
tokyo metropolitan | 32 |
activated macrophages | 32 |
fluorescence microscopy | 32 |
muscle regeneration | 32 |
therapeutic strategy | 32 |
edim virus | 32 |
tohoku univ | 32 |
gene encoding | 32 |
human monoclonal | 32 |
also significantly | 32 |
receptor agonist | 32 |
high level | 32 |
markedly reduced | 32 |
disease course | 32 |
mitochondrial function | 32 |
brain slices | 32 |
dna binding | 32 |
biological activity | 32 |
green fluorescent | 32 |
long pentraxin | 32 |
cord injury | 32 |
also shown | 32 |
lcmv infection | 32 |
hli model | 32 |
spike protein | 32 |
onchocerca volvulus | 32 |
genetic variation | 32 |
proteins involved | 32 |
gene regulation | 32 |
murine norovirus | 32 |
cellular responses | 32 |
infected individuals | 31 |
constitutively expressed | 31 |
phagocytic activity | 31 |
patients suffering | 31 |
open field | 31 |
well established | 31 |
recently identified | 31 |
rna interference | 31 |
acute inflammation | 31 |
dominant negative | 31 |
chemokine receptor | 31 |
pentraxin ptx | 31 |
glutamate receptors | 31 |
basal ganglia | 31 |
may induce | 31 |
marrow cells | 31 |
mice used | 31 |
expressing il | 31 |
microscopic examination | 31 |
induced activation | 31 |
cultured cells | 31 |
high frequency | 31 |
beneficial effect | 31 |
gene product | 31 |
following administration | 31 |
lupus erythematosus | 31 |
normal human | 31 |
athymic mice | 31 |
nuclear factor | 31 |
light microscopic | 31 |
also detected | 31 |
gap junction | 31 |
associated lymphoid | 31 |
avian influenza | 31 |
surface markers | 31 |
recently reported | 31 |
vitro assays | 31 |
cell infiltrates | 31 |
hind limb | 31 |
shear stress | 31 |
expressing human | 31 |
cells using | 31 |
different species | 31 |
receptor antagonists | 31 |
lesser extent | 31 |
tcid ml | 31 |
positive control | 31 |
macrophage activation | 31 |
humanized blt | 30 |
opc differentiation | 30 |
derived macrophages | 30 |
intestinal epithelial | 30 |
solid tumors | 30 |
also reduced | 30 |
neural activity | 30 |
give rise | 30 |
viral proteins | 30 |
using anti | 30 |
clinical outcome | 30 |
world health | 30 |
glutamate receptor | 30 |
zymogen granules | 30 |
control cells | 30 |
cytokine expression | 30 |
receptor potential | 30 |
nonhuman primates | 30 |
cell carcinomas | 30 |
virus isolation | 30 |
thermal injury | 30 |
rift valley | 30 |
following infection | 30 |
mitotic activity | 30 |
old tg | 30 |
studies show | 30 |
inflammatory drugs | 30 |
viral shedding | 30 |
adult brain | 30 |
buffered saline | 30 |
well characterized | 30 |
single dose | 30 |
cardiac function | 30 |
free radicals | 30 |
neurological disease | 30 |
recombinant protein | 30 |
resistant mice | 30 |
inflammatory reactions | 30 |
basal cells | 30 |
prairie dogs | 30 |
barr virus | 30 |
large amounts | 30 |
human cases | 30 |
venous blood | 30 |
dna vaccine | 30 |
adult rat | 30 |
rodent species | 30 |
factor receptor | 30 |
without affecting | 30 |
three times | 30 |
electrical stimulation | 30 |
ng glia | 30 |
bile acid | 30 |
cell transplantation | 30 |
sciatic nerve | 30 |
quantitative real | 30 |
valley fever | 30 |
cytokine secretion | 30 |
bacterial translocation | 30 |
surface area | 30 |
peripheral nerve | 30 |
two major | 30 |
inclusion bodies | 30 |
glutamate transporter | 30 |
therapeutic approaches | 30 |
different stages | 30 |
showed increased | 30 |
complement activation | 30 |
cd mab | 30 |
human neutrophils | 30 |
receptor binding | 30 |
glioma cells | 30 |
growth hormone | 30 |
cells via | 30 |
regulated genes | 30 |
infection may | 30 |
fully understood | 30 |
also demonstrated | 29 |
collagen deposition | 29 |
per day | 29 |
arterial blood | 29 |
mucous cells | 29 |
lavage fluid | 29 |
kg body | 29 |
nkt cell | 29 |
virus may | 29 |
genetic variants | 29 |
specific manner | 29 |
study using | 29 |
significantly attenuated | 29 |
dna adducts | 29 |
pathological changes | 29 |
current study | 29 |
autoimmune encephalomyelitis | 29 |
allergic asthma | 29 |
ctl clones | 29 |
second messenger | 29 |
lassa fever | 29 |
increased numbers | 29 |
may reflect | 29 |
different strains | 29 |
action potential | 29 |
immunohistochemical staining | 29 |
disease pathogenesis | 29 |
cell membranes | 29 |
cre recombinase | 29 |
may include | 29 |
surrounding tissue | 29 |
potential role | 29 |
estrogen receptor | 29 |
tested whether | 29 |
healthy individuals | 29 |
per se | 29 |
infected mouse | 29 |
several days | 29 |
virus ankara | 29 |
glandular mucosa | 29 |
er stress | 29 |
pattern recognition | 29 |
intracerebral inoculation | 29 |
mice carrying | 29 |
full length | 29 |
thermo fisher | 29 |
mouse populations | 29 |
th cytokines | 29 |
cells isolated | 29 |
information processing | 29 |
like structures | 29 |
mhc molecules | 29 |
parietal cells | 29 |
cell repertoire | 29 |
untreated mice | 29 |
pc cells | 29 |
results provide | 29 |
transcriptional regulation | 29 |
brain stem | 29 |
mycoplasma pulmonis | 29 |
complement system | 29 |
human liver | 29 |
fetal bovine | 29 |
showed significantly | 29 |
cellular immunity | 29 |
ischemic stroke | 29 |
bearing mice | 29 |
allowed us | 29 |
systemic lupus | 29 |
auditory cortex | 29 |
significantly improved | 29 |
respiratory epithelium | 29 |
fischer rats | 28 |
dorsal horn | 28 |
infection model | 28 |
flow cytometric | 28 |
cancer therapy | 28 |
physiological role | 28 |
lesions include | 28 |
may serve | 28 |
cells play | 28 |
quantitative rt | 28 |
neonatal rat | 28 |
cell specific | 28 |
correct nose | 28 |
freshly isolated | 28 |
health organization | 28 |
ca pyramidal | 28 |
tlr ligands | 28 |
draining lymph | 28 |
influenza vaccine | 28 |
study showed | 28 |
drg neurons | 28 |
clinical use | 28 |
useful tool | 28 |
early stage | 28 |
clinical course | 28 |
cell mediated | 28 |
dna methylation | 28 |
life sciences | 28 |
rats fed | 28 |
stably transfected | 28 |
peripheral nervous | 28 |
medical research | 28 |
heat shock | 28 |
immune complexes | 28 |
blood levels | 28 |
drug development | 28 |
histological features | 28 |
protein kinases | 28 |
cytokine il | 28 |
proinflammatory cytokine | 28 |
data provide | 28 |
adenoviral vector | 28 |
il rg | 28 |
experimental inoculation | 28 |
nagoya university | 28 |
riken brain | 28 |
magnetic resonance | 28 |
still unknown | 28 |
highly pathogenic | 28 |
cell functions | 28 |
small molecule | 28 |
glandular stomach | 28 |
neutrophil infiltration | 28 |
marrow derived | 28 |
apache ii | 28 |
transient receptor | 28 |
test article | 28 |
might play | 28 |
first days | 28 |
complete regression | 28 |
ach release | 28 |
functional receptor | 28 |
three groups | 28 |
mechanism underlying | 28 |
mean age | 28 |
active infection | 28 |
necrosis may | 28 |
human respiratory | 28 |
several weeks | 28 |
fisher scientific | 28 |
derived cells | 28 |
study suggests | 28 |
studies revealed | 28 |
marked increase | 28 |
wnt signaling | 28 |
lps challenge | 28 |
helicobacter hepaticus | 28 |
laboratory rats | 28 |
acute disease | 28 |
cell lysates | 27 |
one week | 27 |
membrane protein | 27 |
various tissues | 27 |
reverse transcription | 27 |
newly generated | 27 |
higher concentrations | 27 |
ependymal cells | 27 |
completely abolished | 27 |
dependent mechanism | 27 |
mice bearing | 27 |
weeks post | 27 |
positive correlation | 27 |
viral particles | 27 |
week old | 27 |
outbred mice | 27 |
results support | 27 |
levels increased | 27 |
reward learning | 27 |
specific gene | 27 |
human keratinocytes | 27 |
crispr cas | 27 |
three days | 27 |
immune complex | 27 |
elisa kits | 27 |
promoter region | 27 |
response element | 27 |
antigen specific | 27 |
health surveillance | 27 |
factor alpha | 27 |
killer cells | 27 |
enzymatic activity | 27 |
immune status | 27 |
high degree | 27 |
apoptotic cell | 27 |
biologically active | 27 |
cardiac fibroblasts | 27 |
cytokine profile | 27 |
nuclear translocation | 27 |
phosphorylation sites | 27 |
older mice | 27 |
gene family | 27 |
cell patch | 27 |
nhp models | 27 |
severe influenza | 27 |
allergic airway | 27 |
nonglandular stomach | 27 |
aerosol exposure | 27 |
dendritic spines | 27 |
cardiac output | 27 |
clinically relevant | 27 |
cell division | 27 |
cell bodies | 27 |
progenitor cell | 27 |
neoplastic cells | 27 |
present results | 27 |
previous reports | 27 |
alternative splicing | 27 |
result suggests | 27 |
well understood | 27 |
takes place | 27 |
treated cells | 27 |
cytokines il | 27 |
whole cell | 27 |
induced il | 27 |
steady state | 27 |
reovirus infection | 26 |
treated group | 26 |
neural network | 26 |
mice displayed | 26 |
ad libitum | 26 |
parotid gland | 26 |
systemic administration | 26 |
mice injected | 26 |
th th | 26 |
encoding il | 26 |
ms lesions | 26 |
well plates | 26 |
consecutive days | 26 |
increased number | 26 |
two independent | 26 |
cerebral ischemia | 26 |
lps stimulation | 26 |
specific cell | 26 |
light microscopy | 26 |
ampa receptors | 26 |
cynomolgus monkeys | 26 |
liver disease | 26 |
physiological functions | 26 |
transmission electron | 26 |
butylated hydroxyanisole | 26 |
exocrine pancreas | 26 |
will also | 26 |
natural host | 26 |
intratumoral injection | 26 |
locomotor activity | 26 |
increased survival | 26 |
candidate gene | 26 |
also present | 26 |
also show | 26 |
patch clamp | 26 |
comet assay | 26 |
tumour necrosis | 26 |
egg yolk | 26 |
mouse embryo | 26 |
rats following | 26 |
susceptible strains | 26 |
significant correlation | 26 |
also identified | 26 |
icr mice | 26 |
pulmonary syndrome | 26 |
proliferative responses | 26 |
small intestines | 26 |
group ii | 26 |
age related | 26 |
blood cell | 26 |
recombinant inbred | 26 |
hendra virus | 26 |
surface receptors | 26 |
epidemic diarrhea | 26 |
highly sensitive | 26 |
patients undergoing | 26 |
much higher | 26 |
receptive field | 26 |
nude mouse | 26 |
day postinfection | 26 |
proliferative lesions | 26 |
vero cells | 26 |
days pi | 26 |
muscle fibers | 26 |
ill patients | 26 |
united kingdom | 26 |
induced colitis | 26 |
antibodies directed | 26 |
induced arthritis | 26 |
serological tests | 26 |
cardiovascular diseases | 26 |
slice cultures | 26 |
nasal mucosa | 26 |
single cells | 26 |
mice overexpressing | 26 |
related genes | 26 |
basic protein | 26 |
cytotoxic effects | 25 |
mice revealed | 25 |
also important | 25 |
apn transgenic | 25 |
mice vaccinated | 25 |
colon carcinoma | 25 |
present data | 25 |
i will | 25 |
mouse adenovirus | 25 |
venezuelan equine | 25 |
binding activity | 25 |
strongly suggest | 25 |
extensively studied | 25 |
human umbilical | 25 |
cst gene | 25 |
may show | 25 |
neurons showed | 25 |
stromal cells | 25 |
white blood | 25 |
mucosal immune | 25 |
large numbers | 25 |
higher level | 25 |
antigen receptor | 25 |
using flow | 25 |
mice will | 25 |
particle size | 25 |
present work | 25 |
sequence homology | 25 |
fos expression | 25 |
vice versa | 25 |
purkinje cell | 25 |
days postexposure | 25 |
deeper layers | 25 |
rotavirus infection | 25 |
pancreatic acinar | 25 |
conditioned medium | 25 |
control diet | 25 |
chronic stress | 25 |
ctl activity | 25 |
previously demonstrated | 25 |
high incidence | 25 |
pulmonary disease | 25 |
human tissues | 25 |
fold change | 25 |
functional recovery | 25 |
glutamate transporters | 25 |
inhalation exposure | 25 |
studied using | 25 |
acid residues | 25 |
trauma patients | 25 |
murine leukemia | 25 |
primary cultures | 25 |
effector functions | 25 |
tail vein | 25 |
zikv infection | 25 |
antigenic peptides | 25 |
comparative study | 25 |
experiments revealed | 25 |
organ injury | 25 |
animals showed | 25 |
target gene | 25 |
mouse liver | 25 |
much less | 25 |
reovirus type | 25 |
cc strains | 25 |
cell receptors | 25 |
also induced | 25 |
hantavirus pulmonary | 25 |
tumor microenvironment | 25 |
differentially regulated | 25 |
monocytes macrophages | 25 |
broadly neutralizing | 25 |
human diseases | 25 |
cell hybridomas | 25 |
chikungunya virus | 25 |
treatment group | 25 |
inflammatory lesions | 25 |
ovarian cancer | 25 |
defense mechanisms | 25 |
signaling molecules | 25 |
reperfusion injury | 25 |
time rt | 25 |
submandibular glands | 25 |
glutamate release | 25 |
serum igg | 25 |
cell signaling | 25 |
fluorescence intensity | 25 |
lipid mediators | 25 |
aged rats | 25 |
also performed | 25 |
lung diseases | 25 |
muscular dystrophy | 25 |
inflammatory infiltrates | 25 |
pilot study | 25 |
heart disease | 25 |
dna double | 25 |
tyrosine phosphorylation | 24 |
cells compared | 24 |
cd cell | 24 |
endothelial growth | 24 |
columnar cells | 24 |
transduction pathways | 24 |
specific binding | 24 |
myelin basic | 24 |
experimentally induced | 24 |
respiratory system | 24 |
trpc channels | 24 |
recombinant vaccinia | 24 |
lethal dose | 24 |
free radical | 24 |
granule cell | 24 |
different mechanisms | 24 |
also seen | 24 |
fear memory | 24 |
specific pathogen | 24 |
i mhc | 24 |
pcr assays | 24 |
will help | 24 |
dipeptidyl peptidase | 24 |
underlying mechanism | 24 |
neuronal damage | 24 |
vector expressing | 24 |
life science | 24 |
tissue repair | 24 |
environmental conditions | 24 |
insulin signaling | 24 |
days following | 24 |
inducible nitric | 24 |
quantitative pcr | 24 |
following treatment | 24 |
limiting dilution | 24 |
various types | 24 |
localized il | 24 |
least two | 24 |
pandemic influenza | 24 |
induced pulmonary | 24 |
hong kong | 24 |
complex i | 24 |
bal fluid | 24 |
lipid peroxidation | 24 |
lung cancer | 24 |
apoptosis necrosis | 24 |
cell recognition | 24 |
receptor signaling | 24 |
ganglion cells | 24 |
root ganglion | 24 |
mouse thymic | 24 |
urinary bladder | 24 |
small rodents | 24 |
might also | 24 |
highly contagious | 24 |
cryptosporidium parvum | 24 |
glucose uptake | 24 |
cb infection | 24 |
cells expressed | 24 |
mesangial cells | 24 |
blood donors | 24 |
ml kg | 24 |
cell transformation | 24 |
severe combined | 24 |
tc route | 24 |
become infected | 24 |
recent data | 24 |
human coronavirus | 24 |
congo red | 24 |
many tissues | 24 |
goblet cell | 24 |
recent advances | 24 |
open reading | 24 |
virus shedding | 24 |
plasma samples | 24 |
double strand | 24 |
human blood | 24 |
increasing evidence | 24 |
cells transfected | 24 |
analyses revealed | 24 |
per year | 24 |
lethal disease | 24 |
stained sections | 24 |
luciferase reporter | 24 |
mice exhibit | 24 |
genes associated | 24 |
low doses | 24 |
dba mice | 24 |
two days | 24 |
neuronal differentiation | 24 |
cells following | 23 |
gastric glands | 23 |
neural progenitor | 23 |
systemic inflammation | 23 |
post inoculation | 23 |
human il | 23 |
scientific research | 23 |
spinal cords | 23 |
several different | 23 |
cell necrosis | 23 |
still unclear | 23 |
spatial memory | 23 |
swiss mice | 23 |
serine protease | 23 |
brain activity | 23 |
cellular processes | 23 |
human antibodies | 23 |
stressed mice | 23 |
specific differences | 23 |
inoculated mice | 23 |
ach signaling | 23 |
chief cells | 23 |
peripheral tissues | 23 |
vascular endothelium | 23 |
working memory | 23 |
ligand binding | 23 |
specific anti | 23 |
cell apoptosis | 23 |
study demonstrates | 23 |
lung pathology | 23 |
san diego | 23 |
superoxide dismutase | 23 |
medical sciences | 23 |
studies demonstrated | 23 |
smallpox vaccine | 23 |
kinase inhibitor | 23 |
increased significantly | 23 |
therapeutic targets | 23 |
increased production | 23 |
associated molecular | 23 |
death clearly | 23 |
embryonic day | 23 |
severe sepsis | 23 |
mice results | 23 |
clinical features | 23 |
sepsis syndrome | 23 |
using different | 23 |
markedly increased | 23 |
mycobacterium tuberculosis | 23 |
different mouse | 23 |
effective treatment | 23 |
secretory phospholipase | 23 |
suckling mouse | 23 |
cardiac myocytes | 23 |
elevated plus | 23 |
data suggests | 23 |
also examined | 23 |
soft tissue | 23 |
small number | 23 |
mhc i | 23 |
humoral immunity | 23 |
significantly greater | 23 |
provide new | 23 |
model systems | 23 |
barrier function | 23 |
cell body | 23 |
induced dna | 23 |
transmitter release | 23 |
evaluated using | 23 |
increased activity | 23 |
prostate cancer | 23 |
myeloma cells | 23 |
pcr assay | 23 |
human cell | 23 |
experiments using | 23 |
one year | 23 |
mutant mouse | 23 |
sham controls | 23 |
langerhans cells | 23 |
lung homogenates | 23 |
homologous recombination | 23 |
spatial learning | 23 |
among others | 23 |
day pi | 23 |
intravenous injection | 23 |
primary cells | 23 |
eosinophilic cytoplasm | 23 |
derived neurotrophic | 23 |
showed higher | 23 |
mice challenged | 23 |
immune systems | 23 |
oral route | 23 |
tissue tropism | 23 |
highly variable | 23 |
brain areas | 23 |
cell maturation | 23 |
tumor regression | 23 |
laser scanning | 23 |
streptobacillus moniliformis | 23 |
transcript levels | 23 |
four different | 23 |
antibodies may | 23 |
currently investigating | 23 |
mediated activation | 23 |
various cell | 23 |
primate model | 23 |
monoclonal anti | 23 |
helicobacter spp | 23 |
transgenic animals | 23 |
umbilical cord | 23 |
clearly fit | 23 |
nod scid | 23 |
signs include | 23 |
care unit | 23 |
polyclonal antibody | 23 |
atherosclerotic lesions | 23 |
kg i | 23 |
reading frame | 23 |
human tumor | 23 |
study aimed | 23 |
inflammatory effects | 23 |
lineage cells | 23 |
epithelial hyperplasia | 23 |
mouse cells | 23 |
cells per | 23 |
vaccine development | 23 |
synthetic peptide | 23 |
also available | 23 |
mice without | 23 |
light chains | 23 |
wild rodents | 23 |
neural activities | 23 |
tract infection | 23 |
lps injection | 23 |
secreted phospholipase | 23 |
cellular atypia | 23 |
circulating levels | 23 |
gene promoter | 23 |
optical stimulation | 23 |
salmonella typhimurium | 23 |
study investigated | 23 |
disease onset | 22 |
inflammatory properties | 22 |
keio univ | 22 |
fl fl | 22 |
protein tyrosine | 22 |
like particles | 22 |
cellular uptake | 22 |
horseradish peroxidase | 22 |
clamp recordings | 22 |
cells stimulated | 22 |
poly i | 22 |
neuronal migration | 22 |
days prior | 22 |
point mutations | 22 |
motor learning | 22 |
cytokine storm | 22 |
lentiviral vector | 22 |
relatively high | 22 |
mouse antibody | 22 |
regulatory role | 22 |
i antigen | 22 |
gene delivery | 22 |
pneumocystis carinii | 22 |
absorptive cells | 22 |
ros production | 22 |
ischemic injury | 22 |
total protein | 22 |
previous work | 22 |
tlr stimulation | 22 |
brain ischemia | 22 |
observations suggest | 22 |
norovirus infection | 22 |
unclear whether | 22 |
thymic virus | 22 |
specific protein | 22 |
recent evidence | 22 |
alveolar damage | 22 |
subventricular zone | 22 |
model using | 22 |
steroidal anti | 22 |
human genes | 22 |
ca channels | 22 |
oligodendrocyte precursor | 22 |
assay using | 22 |
human testis | 22 |
immune tolerance | 22 |
helicobacter pylori | 22 |
tg mouse | 22 |
acetic acid | 22 |
pv strains | 22 |
heavy chains | 22 |
cell fate | 22 |
weanling mice | 22 |
atopic dermatitis | 22 |
human epididymis | 22 |
gastric acid | 22 |
disease susceptibility | 22 |
ischemia reperfusion | 22 |
systemic disease | 22 |
cell interactions | 22 |
study period | 22 |
also cause | 22 |
negative sepsis | 22 |
previous findings | 22 |
constitutively active | 22 |
macrophage colony | 22 |
murine encephalomyelitis | 22 |
independent experiments | 22 |
animal testing | 22 |
allergic inflammation | 22 |
peritoneal cavity | 22 |
activating factor | 22 |
changes induced | 22 |
severe respiratory | 22 |
various organs | 22 |
riken bsi | 22 |
produce il | 22 |
may act | 22 |
vessel wall | 22 |
hepg cells | 22 |
clinical manifestations | 22 |
free mice | 22 |
recently described | 22 |
cytopathic effect | 22 |
model organism | 22 |
transgene expression | 22 |
breeding colonies | 22 |
cotton rat | 22 |
times higher | 22 |
high expression | 22 |
several types | 22 |
cd antibodies | 22 |
ca release | 22 |
therapeutic intervention | 22 |
predominantly expressed | 22 |
mediated gene | 22 |
cancer research | 22 |
neuroendocrine cells | 22 |
diarrhea virus | 22 |
cecal ligation | 22 |
also investigated | 22 |
intravital microscopy | 22 |
negative controls | 22 |
transcriptional activity | 22 |
also tested | 22 |
varying degrees | 22 |
cell counts | 22 |
also involved | 22 |
igg antibodies | 22 |
test whether | 22 |
cdna library | 22 |
porcine epidemic | 22 |
negative feedback | 22 |
medical science | 22 |
will allow | 22 |
well defined | 22 |
tlr signaling | 22 |
cerebral artery | 22 |
different tissues | 22 |
therapeutic efficacy | 22 |
induced injury | 22 |
fatal disease | 22 |
water maze | 22 |
may contain | 22 |
nod mice | 22 |
sa mix | 22 |
ulcerative colitis | 22 |
forming units | 22 |
zikv inoculation | 22 |
taste cells | 22 |
sensitive dye | 22 |
corpus callosum | 22 |
antibody levels | 22 |
calcium influx | 22 |
burn injury | 22 |
protective efficacy | 21 |
acid substitutions | 21 |
directed mutagenesis | 21 |
semliki forest | 21 |
cell recruitment | 21 |
evidence indicates | 21 |
toxicology program | 21 |
national toxicology | 21 |
animals died | 21 |
host responses | 21 |
small bowel | 21 |
liquid chromatography | 21 |
specific inhibitors | 21 |
new zealand | 21 |
vesicular stomatitis | 21 |
using specific | 21 |
positive neurons | 21 |
cavity pharynx | 21 |
mouse lung | 21 |
functional analysis | 21 |
host genotype | 21 |
th responses | 21 |
cell fusion | 21 |
different concentrations | 21 |
using mouse | 21 |
often used | 21 |
optical imaging | 21 |
insulin sensitivity | 21 |
common cause | 21 |
primary infection | 21 |
bite fever | 21 |
following injury | 21 |
inflammatory changes | 21 |
tnf receptors | 21 |
surface antigen | 21 |
study demonstrated | 21 |
conformational change | 21 |
causes severe | 21 |
stranded dna | 21 |
within weeks | 21 |
growth cones | 21 |
glutamic acid | 21 |
scar formation | 21 |
proteolytic activity | 21 |
also produced | 21 |
host factors | 21 |
another study | 21 |
drug delivery | 21 |
month old | 21 |
primary mouse | 21 |
culture conditions | 21 |
apoptotic bodies | 21 |
littermate controls | 21 |
mhv infections | 21 |
carcinoma cells | 21 |
liver failure | 21 |
vascular injury | 21 |
alcian blue | 21 |
damage response | 21 |
cardiac puncture | 21 |
skeletal muscles | 21 |
surface molecules | 21 |
ubiquitously expressed | 21 |
virus challenge | 21 |
also suggest | 21 |
plaque formation | 21 |
vessel walls | 21 |
molecular patterns | 21 |
much lower | 21 |
experimental evidence | 21 |
major cause | 21 |
regulatory proteins | 21 |
host immunity | 21 |
ca channel | 21 |
nonhuman primate | 21 |
activated receptor | 21 |
norwalk virus | 21 |
expression system | 21 |
ml min | 21 |
middle cerebral | 21 |
drug administration | 21 |
tumor suppressor | 21 |
motor cortex | 21 |
cmv infection | 21 |
marginal zone | 21 |
virus titers | 21 |
may produce | 21 |
basal forebrain | 21 |
vast majority | 21 |
lysis buffer | 21 |
antitumor immunity | 21 |
also able | 21 |
glial scar | 21 |
resonance imaging | 21 |
acid metabolism | 21 |
axon terminals | 21 |
low level | 21 |
increased il | 21 |
vertical transmission | 21 |
cell depletion | 21 |
killer cell | 21 |
viral entry | 21 |
delivery system | 21 |
molecular level | 21 |
glutamate uptake | 21 |
transient increase | 21 |
inner ear | 21 |
experimental infections | 21 |
high titers | 21 |
genetic factors | 21 |
also expressed | 21 |
intranasal route | 21 |
exercise training | 21 |
cause severe | 21 |
test system | 21 |
angiotensin converting | 21 |
surround suppression | 21 |
helper cell | 21 |
type receptor | 21 |
cells increased | 21 |
stratified squamous | 21 |
plus maze | 21 |
tumor development | 21 |
functional properties | 21 |
id route | 21 |
animal facility | 21 |
human exposure | 21 |
side chain | 21 |
cd foxp | 21 |
mouse brains | 21 |
calcium channels | 21 |
target proteins | 21 |
human macrophages | 21 |
receptor mediated | 21 |
tandem mass | 21 |
immunocompromised mice | 21 |
fetal liver | 21 |
two strains | 21 |
memory formation | 21 |
cell tolerance | 21 |
mouse colony | 21 |
associated protein | 21 |
metropolitan institute | 21 |
disease models | 21 |
organ damage | 21 |
induced cytokine | 21 |
lung disease | 21 |
detected using | 21 |
study shows | 21 |
calf serum | 21 |
bla ach | 21 |
infrared spectroscopy | 21 |
i expression | 21 |
urinary tract | 21 |
antibiotic therapy | 21 |
study also | 21 |
recombinant mva | 21 |
camp levels | 20 |
expression profiling | 20 |
two species | 20 |
postsynaptic currents | 20 |
surviving mice | 20 |
tnf receptor | 20 |
neutrophil recruitment | 20 |
seven days | 20 |
tissue homogenates | 20 |
viral diseases | 20 |
recombinant proteins | 20 |
kinase activity | 20 |
possible mechanism | 20 |
brain research | 20 |
show signs | 20 |
silver nanoparticles | 20 |
cell lysis | 20 |
cell morphology | 20 |
statistical analyses | 20 |
quantitative trait | 20 |
genetically diverse | 20 |
activated cell | 20 |
diarrheal disease | 20 |
arterial pressure | 20 |
da neurons | 20 |
transplantable tumours | 20 |
melanoma cells | 20 |
cycle progression | 20 |
minor salivary | 20 |
listeria monocytogenes | 20 |
data showed | 20 |
interstitial fibrosis | 20 |
endotracheal tube | 20 |
almost completely | 20 |
female reproductive | 20 |
early postnatal | 20 |
showed high | 20 |
well documented | 20 |
vivo experiments | 20 |
challenged mice | 20 |
virus disease | 20 |
severely affected | 20 |
day postexposure | 20 |
cytosolic ca | 20 |
stem progenitor | 20 |
express il | 20 |
vivo models | 20 |
th day | 20 |
significantly larger | 20 |
antigen expression | 20 |
primary motor | 20 |
polyclonal antibodies | 20 |
mammary tumors | 20 |
functional roles | 20 |
university medical | 20 |
infection occurs | 20 |
also susceptible | 20 |
cells might | 20 |
similar changes | 20 |
analysis indicated | 20 |
cytometry analysis | 20 |
mainly due | 20 |
animal facilities | 20 |
peptide binding | 20 |
nuclear extracts | 20 |
filovirus infection | 20 |
biological samples | 20 |
chemically induced | 20 |
published data | 20 |
male infertility | 20 |
systematic review | 20 |
vivo model | 20 |
host resistance | 20 |
findings show | 20 |
human gene | 20 |
observation period | 20 |
extracellular space | 20 |
using whole | 20 |
fear conditioning | 20 |
body fluids | 20 |
lps induced | 20 |
signalling molecules | 20 |
endocrine cells | 20 |
vitro stimulation | 20 |
species differences | 20 |
induced demyelination | 20 |
use committee | 20 |
neural cells | 20 |
quantitative analysis | 20 |
nerve regeneration | 20 |
th response | 20 |
recombinant adenovirus | 20 |
cell lymphoma | 20 |
rat spinal | 20 |
genes identified | 20 |
nucleic acid | 20 |
mouse cst | 20 |
certain strains | 20 |
cell tumor | 20 |
antigen recognition | 20 |
powerful tool | 20 |
cultured rat | 20 |
die within | 20 |
breast milk | 20 |
rna virus | 20 |
developing brain | 20 |
binding assays | 20 |
mice aged | 20 |
neurodegenerative disease | 20 |
transcriptional level | 20 |
also measured | 20 |
immune activation | 20 |
long periods | 20 |
chronic pain | 20 |
regulatory mechanisms | 20 |
specific activity | 20 |
clinical study | 20 |
therapeutic approach | 20 |
intranuclear inclusions | 20 |
hunched posture | 20 |
acid oxidation | 20 |
african green | 20 |
cell therapy | 20 |
capsid protein | 20 |
examine whether | 20 |
histological analysis | 20 |
neointima formation | 20 |
artery occlusion | 20 |
five days | 20 |
chronic treatment | 20 |
loaded microspheres | 20 |
old rats | 20 |
functional significance | 20 |
induced increase | 20 |
rattus norvegicus | 20 |
late phase | 20 |
dependent increase | 20 |
node cells | 20 |
bladder cancer | 20 |
short term | 20 |
significantly less | 20 |
igg response | 20 |
advancing age | 20 |
goat anti | 20 |
neointimal hyperplasia | 20 |
schwann cell | 20 |
human recombinant | 20 |
synaptic vesicles | 20 |
synaptic inputs | 20 |
recent findings | 20 |
immune suppression | 20 |
reporter mice | 20 |
tyrosine kinases | 20 |
murid herpesvirus | 20 |
three mice | 20 |
frontal cortex | 20 |
plaque assay | 20 |
visual information | 20 |
cytokine profiles | 20 |
proliferative activity | 20 |
vitro methods | 20 |
receptor subtypes | 20 |
viral persistence | 20 |
affected animals | 20 |
available elisa | 20 |
nerve fibers | 20 |
synapse formation | 20 |
seasonal influenza | 20 |
kda protein | 20 |
rat liver | 20 |
blood vessel | 20 |
also occurs | 20 |
induced neointimal | 19 |
terminal region | 19 |
small amounts | 19 |
satellite cells | 19 |
umami taste | 19 |
eastern equine | 19 |
ri strains | 19 |
mouse genes | 19 |
epidemiological studies | 19 |
muscle cell | 19 |
somatosensory cortex | 19 |
energy transfer | 19 |
take place | 19 |
human ace | 19 |
physiologically relevant | 19 |
cells treated | 19 |
disease process | 19 |
chronically stressed | 19 |
visual stimuli | 19 |
digestive system | 19 |
inflammatory genes | 19 |
vad male | 19 |
low density | 19 |
clinical isolate | 19 |
neuronal function | 19 |
digestive tract | 19 |
fold lower | 19 |
two cell | 19 |
see chapter | 19 |
interferon gamma | 19 |
calcium channel | 19 |
nagoya univ | 19 |
presynaptic terminals | 19 |
basic research | 19 |
serological testing | 19 |
xenopus laevis | 19 |
i ii | 19 |
two genes | 19 |
olfactory system | 19 |
catalytic subunit | 19 |
congo hemorrhagic | 19 |
mouse embryos | 19 |
term memory | 19 |
gray matter | 19 |
quantified using | 19 |
broad spectrum | 19 |
subcellular localization | 19 |
likely present | 19 |
structural proteins | 19 |
cerebrospinal fluid | 19 |
new model | 19 |
single amino | 19 |
focally extensive | 19 |
lesions may | 19 |
disease model | 19 |
th cytokine | 19 |
atypical hyperplasia | 19 |
analysed using | 19 |
human mabs | 19 |
least three | 19 |
mean arterial | 19 |
matrix proteins | 19 |
useful model | 19 |
based vaccine | 19 |
first line | 19 |
postnatal development | 19 |
virus persistence | 19 |
transcriptional activation | 19 |
pharmacological inhibition | 19 |
genes encoding | 19 |
otitis media | 19 |
receptor tyrosine | 19 |
infected colonies | 19 |
patients without | 19 |
mycoplasmal infections | 19 |
hematopoietic cells | 19 |
term survival | 19 |
biological processes | 19 |
pichinde virus | 19 |
motor neuron | 19 |
ion channel | 19 |
experiments showed | 19 |
bd biosciences | 19 |
calcium signaling | 19 |
channel activity | 19 |
may require | 19 |
analysis demonstrated | 19 |
neurological symptoms | 19 |
injected mice | 19 |
molecular layer | 19 |
derived growth | 19 |
common marmosets | 19 |
specific antigen | 19 |
histological changes | 19 |
gondii infection | 19 |
concentration range | 19 |
cyclic nucleotide | 19 |
jurkat cells | 19 |
viral clearance | 19 |
neuronal survival | 19 |
systemic circulation | 19 |
highly specific | 19 |
nuclear receptor | 19 |
atherosclerotic plaques | 19 |
cytomegalovirus infection | 19 |
gene silencing | 19 |
promising therapeutic | 19 |
feeding behavior | 19 |
urine samples | 19 |
located within | 19 |
reduced expression | 19 |
results demonstrated | 19 |
stomatitis virus | 19 |
response syndrome | 19 |
vaccine delivery | 19 |
male mouse | 19 |
glial activation | 19 |
study provides | 19 |
test articles | 19 |
cellular level | 19 |
opportunistic infections | 19 |
important factor | 19 |
viral hepatitis | 19 |
using mice | 19 |
host genetic | 19 |
primary rat | 19 |
olfactory dysfunction | 19 |
significant increases | 19 |
limited number | 19 |
negative control | 19 |
oligodendrocyte progenitor | 19 |
different brain | 19 |
human fetal | 19 |
colonic mucosa | 19 |
transplantable tumors | 19 |
variable regions | 19 |
may alter | 19 |
kupffer cells | 19 |
immunosuppressed mice | 19 |
heparan sulfate | 19 |
drug discovery | 19 |
rat mite | 19 |
plasmid dna | 19 |
also possible | 19 |
i antigens | 19 |
secreting cells | 19 |
mouse embryonic | 19 |
similar neoplastic | 19 |